How does once-weekly subcutaneous tirzepatide affect maintenance of weight loss in individuals with obesity or overweight?
No takes yet. Share an insight, caveat, or question.
Aronne et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: